FDA has approved Lipfendra, developed by American pharmaceutical company Merck, for adults with high LDL cholesterol. It ...
The FDA has approved Merck's once-daily cholesterol pill Lipfendra (enlicitide), marking the first oral PCSK9 inhibitor.
Woman's World on MSN
New cholesterol pill Lipfendra now approved: How it stacks up to statins
While tried-and-true high cholesterol treatments like statins are an important way to protect your heart if you have elevated ...
The FDA has approved Lipfendra, the first oral PCSK9 inhibitor, for the treatment of high cholesterol. Two medical experts explain why this matters.
A significant breakthrough in heart disease prevention arrived on July 16, 2026, with the FDA approval of Lipfendra ...
Gold has a long history in medicine, but experts warn its legitimate uses bear no resemblance to dangerous online claims. It ...
Morning Overview on MSN
The FDA approved a first-of-its-kind pill that cuts stubborn cholesterol like the costly injections
Millions of adults whose cholesterol stays dangerously high despite taking statins now have a new option that does not ...
The FDA has approved a first-of-its-kind pill that can lower "bad" LDL cholesterol with a daily pill instead of a shot.
High cholesterol is one of the major risk factors for heart disease and stroke. While statins have been the most common ...
The USFDA has approved Lipfendra, the first oral PCSK9 inhibitor, for lowering LDL cholesterol. The once-daily pill could improve long-term adherence, though Indian access will depend on approval and ...
Living with an autoimmune condition demands relentless vigilance. For individuals diagnosed with Type 1 diabetes , daily ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results